Priti Pednekar
Astellas Pharma (United States)
ORCID: 0000-0002-0543-6677MedicineImmunology and Microbiology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 1 paper. Top paper: “Real-world treatment adherence and persistence of FLT3 inhibitors as post-alloHCT maintenance therapy in patients with AML in the United States: a cohort study using administrative claims data”.
2 citations
Maëlys Touya, James Spalding, C. Young, Lingtao Frank Cao, David Nimke +3 more